PB&B receives an additional CHF 1 M equity investment

PB&B receives an additional CHF 1 M equity investment

18.7.2017 Medtech startup PB&B has received an additional CHF 1 million equity investment from its strategic investor. This investment will be allocated to launching the first-in-human clinical trial in 2018 for volume restauration of aging midface.

Read more…